2025年胃癌诊断全球市场报告

近年来，胃癌诊断市场规模呈现强劲成长势头，从2024年的25.9亿美元成长至2025年的27.8亿美元，复合年增长率达7.3%。这段历史性时期的成长可归因于幽门螺旋桿菌感染率的上升、人们对胃癌症状认识的提高、老龄化人口中胃癌发病率的上升、熏制和保存食品消费量的增加，以及高危险群中诊断筛检应用的增加。

预计未来几年胃癌诊断市场规模将强劲成长，2029年将达到36.3亿美元，复合年增长率为6.9%。预测期内的成长可归因于对早期检测和筛检项目的需求不断增长、针对胃癌预防的宣传宣传活动日益增多、个人化医疗方法的日益普及、新兴市场医疗基础设施的不断扩展，以及对非侵入性和快速诊断检测的日益重视。这段时期的主要趋势包括分子诊断技术的进步、用于提高诊断准确性的生物标记组的开发、携带式照护现场诊断设备的开发、微创诊断工具的创新以及成像模式的整合。

胃癌诊断涉及多种测试和程序来检测和确认胃癌的存在，主要目的是及早发现胃肿瘤，确定肿瘤的类型和阶段，并支持有效的治疗计划。

胃癌诊断的主要类型包括内视镜检查、影像学检查、切片检查、临床检测和基于生物标记的检测。内视镜检查需要插入配备摄影机和光源的柔性管，以目视检查内部器官和组织。这些诊断中使用的产品包括试剂、耗材和仪器，所使用的技术涵盖分子诊断、免疫检测测定和次世代定序等。这些诊断方法用于早期检测、筛检和疾病监测，服务于广泛的终端用户，包括医院、诊所、诊断实验室和其他医疗机构。

美国关税的快速上涨以及随之而来的始于2025年春季的贸易摩擦，对医疗设备行业产生了重大影响，尤其对进口诊断影像设备零件、手术用不銹钢和塑胶耗材产生了重大影响。医院和诊所抵制涨价，挤压了製造商的净利率。监管障碍加剧了这个问题，因为与关税相关的供应商变更通常需要设备重新认证，从而延缓了产品上市时间。企业正在透过双重采购关键零件、扩大国内商品化生产以及加快高性价比材料的研发来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供胃癌诊断市场统计数据，例如全球市场规模、区域份额、胃癌诊断市场份额竞争对手、详细的胃癌诊断细分市场、市场趋势和商业机会，以及您在胃癌诊断行业取得成功所需的数据。本胃癌诊断市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

胃癌发生率的上升预计将推动胃癌诊断市场的成长。胃癌是胃黏膜的恶性肿瘤，当细胞不受控制地增生、侵入周围组织并发生转移时就会发生。患者数量的增加主要是由于不健康的饮食习惯，包括大量摄取盐渍、熏制和加工食品，这些食物会损害胃黏膜并增加癌症风险。胃癌诊断有助于早期发现恶性病变，从而及时治疗并改善患者预后。提供快速且准确的结果可提高临床效率并支持更好的疾病管理。例如，美国癌症协会报告称，2024年5月美国新增胃癌病例26,890例，高于2023年的26,500例，凸显了对有效诊断解决方案日益增长的需求。

该市场中的公司正在利用人工智慧驱动的内视镜诊断工具进行创新，以提高早期检测率和准确性。人工智慧驱动的内视镜诊断支援设备在内视镜检查期间即时分析视讯影像，以检测胃肠道异常，包括早期癌症。 2024年3月，日本医疗科技公司AI医疗服务株式会社推出了GastroAI-model G，该模型利用深度学习在内视镜萤幕上突出显示可疑病变，并立即提醒医生进行进一步检查或切片检查。这项技术创新提高了诊断准确性并实现了早期疗育，这对于改善患者预后至关重要。

2025年4月，总部位于丹麦的微生物检测公司SSI Diagnostica Group收购了墨西哥湾沿岸地区 Scientific Corporation，这是一家专注于幽门螺旋桿菌检测以检测胃癌风险的美国诊断公司。此次收购增强了SSI Diagnostica的胃肠道疾病检测能力，提升了其在美国诊断市场的份额，并透过胃癌诊断领域的创新和互补技术来支持其成长。

胃癌诊断市场由提供遗传咨询、风险评估计划、远距病理咨询和患者导航服务等服务的营业单位所获得的收益构成。市场价值还包括服务提供者销售或包含在其服务产品中的相关产品的价值。胃癌诊断市场还包括液态切片套件、快速诊断测试 (RDT) 设备、数位病理扫描仪、诊断造影和实验室晶片系统的销售。该市场的价值是“出厂价”，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场中的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球胃癌诊断：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球胃癌诊断市场：成长率分析
• 全球胃癌诊断市场表现：规模与成长，2019-2024
• 全球胃癌诊断市场预测：规模与成长，2024-2029年，2034年
• 全球胃癌诊断：总目标市场（TAM）

第六章 市场细分

• 全球胃癌诊断市场（依诊断类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
• 内视镜检查
• 影像学
• 切片检查
• 实验室检查
• 基于生物标誌物的测试
• 全球胃癌诊断市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 试剂和耗材
• 装置
• 全球胃癌诊断市场：依技术、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 分子诊断
• 免疫检测
• 次世代定序
• 其他技术
• 全球胃癌诊断市场：应用、绩效及预测（2019-2024年、2024-2029年、2034年）
• 早期诊断
• 筛检
• 监控
• 全球胃癌诊断市场：按最终用户、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
• 医院
• 诊所
• 诊断实验室
• 其他最终用户
• 全球胃癌诊断市场：内视镜细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 常规内视镜检查
• 色镜学
• 窄频成像
• 共聚焦雷射内视镜
• 胶囊内视镜
• 全球胃癌诊断市场：依影像（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 电脑断层扫描
• 磁振造影
• 正子断层扫描
• 超音波
• X射线
• 全球胃癌诊断市场：依切片检查类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
• 钳式切片检查
• 针吸切片
• 超音波切片检查
• 腹腔镜切片检查
• 全球胃癌诊断市场：依临床试验（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 血液检查
• 粪便检验
• 尿素呼气试验
• 血清学
• 全球胃癌诊断市场：基于生物标记检测的细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 基因检测
• 蛋白质生物标记检测
• 循环肿瘤DNA检测
• MicroRNA检测

第七章 区域和国家分析

• 全球胃癌诊断市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球胃癌诊断市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 胃癌诊断市场：竞争格局
• 胃癌诊断市场：公司简介
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Agilent Technologies Inc.
• Illumina Inc.
• bioMerieux SA
• Qiagen NV
• DiaSorin SpA
• Natera Inc.
• Myriad Genetics Inc.
• Fulgent Genetics Inc.
• Foundation Medicine Inc.
• Invitae Corporation
• NeoGenomics Laboratories Inc.
• Fujirebio Inc.
• MiRXES Pte Ltd.
• BIOCEPT Inc.
• Pillar Biosciences Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

• 2029年胃癌诊断市场：提供新机会的国家
• 2029年胃癌诊断市场：细分领域带来新机会
• 2029年胃癌诊断市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

Gastric cancer diagnostics encompass a range of tests and procedures designed to detect and confirm the presence of cancer in the stomach. Their primary objective is to identify gastric tumors at an early stage, determine tumor type and progression, and support effective treatment planning.

The primary types of gastric cancer diagnostics include endoscopy, imaging, biopsy, laboratory tests, and biomarker-based testing. Endoscopy involves inserting a flexible tube equipped with a camera and light to visually examine internal organs and tissues. The products used in these diagnostics include reagents, consumables, and instruments, while the technologies employed range from molecular diagnostics and immunoassays to next-generation sequencing and others. These diagnostics are applied for early detection, screening, and disease monitoring, catering to a wide range of end users such as hospitals, clinics, diagnostic laboratories, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The gastric cancer diagnostic market research report is one of a series of new reports from The Business Research Company that provides gastric cancer diagnostic market statistics, including gastric cancer diagnostic industry global market size, regional shares, competitors with a gastric cancer diagnostic market share, detailed gastric cancer diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the gastric cancer diagnostic industry. This gastric cancer diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastric cancer diagnostic market size has grown strongly in recent years. It will grow from $2.59 billion in 2024 to $2.78 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be attributed to the rising prevalence of *Helicobacter pylori* infections, increasing awareness of gastric cancer symptoms, higher incidence of gastric cancer among aging populations, greater consumption of smoked and preserved foods, and the expanding use of diagnostic screening in high-risk groups.

The gastric cancer diagnostic market size is expected to see strong growth in the next few years. It will grow to $3.63 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to the increasing demand for early detection and screening programs, rising awareness campaigns focused on gastric cancer prevention, growing adoption of personalized medicine approaches, expansion of healthcare infrastructure in emerging markets, and heightened emphasis on non-invasive and rapid diagnostic tests. Key trends during this period include advancements in molecular diagnostic technologies, development of biomarker panels to enhance diagnostic accuracy, creation of portable point-of-care diagnostic devices, innovation in minimally invasive diagnostic tools, and integration of imaging modalities.

The rising incidence of gastric cancer is expected to drive growth in the gastric cancer diagnostic market. Gastric cancer, a malignant tumor of the stomach lining, develops when cells grow uncontrollably and can invade surrounding tissues or metastasize. The increase in cases is largely attributed to unhealthy dietary habits, including high consumption of salted, smoked, and processed foods, which damage the stomach lining and elevate cancer risk. Gastric cancer diagnostics facilitate early detection of malignant lesions, enabling timely treatment and improved patient outcomes. They enhance clinical efficiency by providing rapid and accurate results that support better disease management. For example, in May 2024, the American Cancer Society reported 26,890 new stomach cancer cases in the U.S., up from 26,500 in 2023, highlighting the growing need for effective diagnostic solutions.

Companies in this market are innovating with AI-powered endoscopic diagnostic tools to improve early detection and accuracy. AI-based endoscopic diagnostic support devices analyze video images in real time during endoscopy to detect gastrointestinal abnormalities, including early-stage cancer. In March 2024, AI Medical Service Inc., a Japan-based medical technology company, launched GastroAI-model G, which uses deep learning to highlight suspicious lesions on the endoscopic screen, alerting physicians instantly for further examination or biopsy. This innovation improves diagnostic accuracy and enables earlier intervention, which is critical for better patient outcomes.

In April 2025, SSI Diagnostica Group, a Denmark-based microbiology company, acquired Gulf Coast Scientific Corporation, a U.S.-based diagnostics firm specializing in H. pylori testing for gastric cancer risk detection. This acquisition strengthens SSI Diagnostica's gastrointestinal disease testing capabilities, enhances its presence in the U.S. diagnostics market, and supports growth through innovation and complementary technology in gastric cancer diagnostics.

Major players in the gastric cancer diagnostic market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

North America was the largest region in the gastric cancer diagnostic market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastric cancer diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gastric cancer diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric cancer diagnostic market consists of revenues earned by entities by providing services such as genetic counselling, risk assessment programmes, telepathology consultations, and patient navigation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastric cancer diagnostics market also includes sales of liquid biopsy kits, rapid diagnostic test (RDT) devices, digital pathology scanners, contrast agents for imaging, and lab-on-a-chip systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastric Cancer Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastric cancer diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastric cancer diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastric cancer diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Diagnostic Type: Endoscopy; Imaging; Biopsy; Laboratory Tests; Biomarker-Based Testing
• 2) By Product: Reagents And Consumables; Instruments
• 3) By Technology: Molecular Diagnostics; Immunoassays; Next-Generation Sequencing; Other Technologies
• 4) By Application: Early Diagnosis; Screening; Monitoring
• 5) By End User: Hospitals; Clinics; Diagnostic Laboratories; Other End Users
• Subsegments:
• 1) By Endoscopy: Conventional Endoscopy; Chromoendoscopy; Narrow Band Imaging; Confocal Laser Endomicroscopy; Capsule Endoscopy
• 2) By Imaging: Computed Tomography; Magnetic Resonance Imaging; Positron Emission Tomography; Ultrasound
• 3) By Biopsy: Forceps Biopsy; Needle Biopsy; Endoscopic Ultrasound-Guided Biopsy; Laparoscopic Biopsy
• 4) By Laboratory Tests: Blood Tests; Stool Tests; Urea Breath Test; Serology
• 5) By Biomarker-Based Testing: Genetic Testing; Protein Biomarker Testing; Circulating Tumor DNA Testing; Microribonucleic Acid Testing
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson and Company; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; bioMerieux SA; Qiagen N.V.; DiaSorin S.p.A; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; Foundation Medicine Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Fujirebio Inc.; MiRXES Pte Ltd.; BIOCEPT Inc.; Pillar Biosciences Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastric Cancer Diagnostic Market Characteristics

3. Gastric Cancer Diagnostic Market Trends And Strategies

4. Gastric Cancer Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gastric Cancer Diagnostic Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gastric Cancer Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gastric Cancer Diagnostic Market Growth Rate Analysis
• 5.4. Global Gastric Cancer Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gastric Cancer Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gastric Cancer Diagnostic Total Addressable Market (TAM)

6. Gastric Cancer Diagnostic Market Segmentation

• 6.1. Global Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endoscopy
• Imaging
• Biopsy
• Laboratory Tests
• Biomarker-Based Testing
• 6.2. Global Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Consumables
• Instruments
• 6.3. Global Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Molecular Diagnostics
• Immunoassays
• Next-Generation Sequencing
• Other Technologies
• 6.4. Global Gastric Cancer Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early Diagnosis
• Screening
• Monitoring
• 6.5. Global Gastric Cancer Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Diagnostic Laboratories
• Other End Users
• 6.6. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Endoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Endoscopy
• Chromoendoscopy
• Narrow Band Imaging
• Confocal Laser Endomicroscopy
• Capsule Endoscopy
• 6.7. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Imaging, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Computed Tomography
• Magnetic Resonance Imaging
• Positron Emission Tomography
• Ultrasound
• X-ray
• 6.8. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Forceps Biopsy
• Needle Biopsy
• Endoscopic Ultrasound-Guided Biopsy
• Laparoscopic Biopsy
• 6.9. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Laboratory Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• Stool Tests
• Urea Breath Test
• Serology
• 6.10. Global Gastric Cancer Diagnostic Market, Sub-Segmentation Of Biomarker-Based Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing
• Protein Biomarker Testing
• Circulating Tumor DNA Testing
• MicroRibonucleic Acid Testing

7. Gastric Cancer Diagnostic Market Regional And Country Analysis

• 7.1. Global Gastric Cancer Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gastric Cancer Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastric Cancer Diagnostic Market

• 8.1. Asia-Pacific Gastric Cancer Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastric Cancer Diagnostic Market

• 9.1. China Gastric Cancer Diagnostic Market Overview
• 9.2. China Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastric Cancer Diagnostic Market

• 10.1. India Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastric Cancer Diagnostic Market

• 11.1. Japan Gastric Cancer Diagnostic Market Overview
• 11.2. Japan Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastric Cancer Diagnostic Market

• 12.1. Australia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastric Cancer Diagnostic Market

• 13.1. Indonesia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastric Cancer Diagnostic Market

• 14.1. South Korea Gastric Cancer Diagnostic Market Overview
• 14.2. South Korea Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastric Cancer Diagnostic Market

• 15.1. Western Europe Gastric Cancer Diagnostic Market Overview
• 15.2. Western Europe Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastric Cancer Diagnostic Market

• 16.1. UK Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastric Cancer Diagnostic Market

• 17.1. Germany Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastric Cancer Diagnostic Market

• 18.1. France Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastric Cancer Diagnostic Market

• 19.1. Italy Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastric Cancer Diagnostic Market

• 20.1. Spain Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastric Cancer Diagnostic Market

• 21.1. Eastern Europe Gastric Cancer Diagnostic Market Overview
• 21.2. Eastern Europe Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastric Cancer Diagnostic Market

• 22.1. Russia Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastric Cancer Diagnostic Market

• 23.1. North America Gastric Cancer Diagnostic Market Overview
• 23.2. North America Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastric Cancer Diagnostic Market

• 24.1. USA Gastric Cancer Diagnostic Market Overview
• 24.2. USA Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastric Cancer Diagnostic Market

• 25.1. Canada Gastric Cancer Diagnostic Market Overview
• 25.2. Canada Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastric Cancer Diagnostic Market

• 26.1. South America Gastric Cancer Diagnostic Market Overview
• 26.2. South America Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastric Cancer Diagnostic Market

• 27.1. Brazil Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastric Cancer Diagnostic Market

• 28.1. Middle East Gastric Cancer Diagnostic Market Overview
• 28.2. Middle East Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastric Cancer Diagnostic Market

• 29.1. Africa Gastric Cancer Diagnostic Market Overview
• 29.2. Africa Gastric Cancer Diagnostic Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gastric Cancer Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gastric Cancer Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastric Cancer Diagnostic Market Competitive Landscape And Company Profiles

• 30.1. Gastric Cancer Diagnostic Market Competitive Landscape
• 30.2. Gastric Cancer Diagnostic Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Gastric Cancer Diagnostic Market Other Major And Innovative Companies

• 31.1. Agilent Technologies Inc.
• 31.2. Illumina Inc.
• 31.3. bioMerieux SA
• 31.4. Qiagen N.V.
• 31.5. DiaSorin S.p.A
• 31.6. Natera Inc.
• 31.7. Myriad Genetics Inc.
• 31.8. Fulgent Genetics Inc.
• 31.9. Foundation Medicine Inc.
• 31.10. Invitae Corporation
• 31.11. NeoGenomics Laboratories Inc.
• 31.12. Fujirebio Inc.
• 31.13. MiRXES Pte Ltd.
• 31.14. BIOCEPT Inc.
• 31.15. Pillar Biosciences Inc.

32. Global Gastric Cancer Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastric Cancer Diagnostic Market

34. Recent Developments In The Gastric Cancer Diagnostic Market

35. Gastric Cancer Diagnostic Market High Potential Countries, Segments and Strategies

• 35.1 Gastric Cancer Diagnostic Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gastric Cancer Diagnostic Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gastric Cancer Diagnostic Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer